CLINICAL_TRIALS
trial_result
· 2013-06-27
Clinical Trial Update: Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial [Phase 2]
Summary
This clinical trial update describes a Phase 2 study of dasatinib in patients with chronic myeloid leukemia in chronic phase who have achieved complete molecula…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kanto CML Study Group | Conditions: Myelogenous Leukemia, Chronic, Chronic Phase | Phase 2 | Status: UNKNOWN